Capital DailyCapital Daily
Finance

Nvidia CEO Jensen Huang Said AI's "Most Profound Impact Will Be in Life Sciences." Does This Bet on a Biotech Stock Prove He Means It?

One small investment offers big benefits for Nvidia.

Nvidia CEO Jensen Huang Said AI's "Most Profound Impact Will Be in Life Sciences." Does This Bet on a Biotech Stock Prove He Means It?

Published July 11, 2026 · Category: Finance

Overview

Nvidia (NASDAQ: NVDA) is known as one of the most advanced makers of chips powering the breakthroughs in artificial intelligence (AI). But what some people may not know is that Nvidia is also an investor in other companies. 

Among its investments, it holds stakes in cloud computing provider CoreWeave, chip designer and manufacturer Intel, and telecommunications company Nokia. But at the bottom of one of its May financial filings, it also listed an investment in a small biotech company: Generate Biomedicines (NASDAQ: GENB).

Details

That may not seem to fit the pattern of investing in tech operators. But Nvidia CEO Jensen Huang sees an important intersection between the healthcare field and AI.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.